OncoMatch/Clinical Trials/NCT06712420
Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)
Is NCT06712420 recruiting? Yes, currently enrolling (Jun 2026). This Phase 3 trial studies neoadjuvant chemotherapy for gall bladder carcinoma.
Treatment: neoadjuvant chemotherapy — to study role of chemotherapy treatment for gall bladder cancer before surgery as compared to surgery directly
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Cholangiocarcinoma
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Demographics
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT06712420 currently recruiting?
Yes, this trial is currently recruiting patients.
Is there an age limit?
Yes. Patients must be 70 years or younger.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages